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Abstract
Bonvital® is the trade name for a feed additive based on Enterococcus faecium DSM 7134 currently
authorised for use in piglets, pigs for fattening, sows, chickens for fattening, chickens reared for laying
and minor poultry species. This opinion concerns the renewal of the authorisation of Bonvital® as a
zootechnical additive for weaned piglets and pigs for fattening. The applicant is proposing to increase
the minimum and maximum inclusion level of the additive in feed for weaned piglets and the
maximum for pigs for fattening. The applicant has provided data demonstrating that the additive
currently in the market complies with the conditions of authorisation. E. faecium DSM 7134 does not
belong to the hospital-associated clade and does not express resistance to the antibiotics tested;
therefore, its use in animal nutrition is considered safe for the target animals and consumers of animal
products. Bonvital® is also considered safe for the target animals and consumers. In previous opinions,
Bonvital® was found to be non-irritant to skin and eyes, but a potential skin/respiratory sensitiser and
safe for the environment. No new evidence has been identiﬁed that would make the Panel reconsider
the previous conclusions on the safety of the additive. The conclusions reached before are considered
to cover the higher maximum application rates proposed by the applicant. Therefore, the
Panel concludes that Bonvital® used under the proposed conditions of use is safe for weaned piglets
and pigs for fattening, consumers of products derived from animals fed Bonvital® and the
environment. Bonvital® is considered a potential skin/respiratory sensitiser. The additional studies
provided conﬁrm that Bonvital® has the potential to be efﬁcacious in weaned piglets at 1 9 109 colony
forming unit (CFU)/kg feed and in pigs for fattening at 2 9 108 CFU/kg feed.
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1. Introduction
1.1. Background and Terms of Reference
Regulation (EC) No 1831/20031 establishes the rules governing the Community authorisation of
additives for use in animal nutrition. In particular, Article 14 of that Regulation speciﬁes that for
products authorised according to Article 9, an application for renewal shall be submitted in accordance
with Article 7, at the latest one year before the expiry date of the authorisation.
The European Commission received two requests from Lactosan GmbH & Co.Kg2 for renewal of the
authorisation of the product Bonvital® (Enterococcus faecium DSM 7134), one when used as a feed
additive for weaned piglets and one for pigs for fattening (category: zootechnical additive; functional
group: gut ﬂora stabiliser).
According to Article 7(1) of Regulation (EC) No 1831/2003, the Commission forwarded the
applications to the European Food Safety Authority (EFSA) as applications under Article 14(1) (renewal
of an authorised feed additive). EFSA received directly from the applicant the technical dossiers in
support of these applications. The particulars and documents in support of the applications were
considered valid by EFSA as of 5 October 2016.
According to Article 8 of Regulation (EC) No 1831/2003, EFSA, after verifying the particulars and
documents submitted by the applicant, shall undertake an assessment in order to determine whether
the feed additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on
the safety for the target animals, consumer, user and the environment and on the efﬁcacy of the
product Bonvital (Enterococcus faecium DSM 7134), when used under the proposed conditions of use
(see Section 3.1.3).
1.2. Additional information
EFSA issued several opinions on the product when used with chickens for fattening (EFSA, 2004),
piglets and pigs for fattening (EFSA, 2007a), sows (EFSA, 2007b; EFSA FEEDAP Panel, 2014), dogs (EFSA,
2009a), chickens for fattening (EFSA, 2009b; EFSA FEEDAP Panel, 2010) and chickens reared for laying
and minor avian species (EFSA FEEDAP Panel, 2013a). EFSA issued an opinion on the safety and efﬁcacy
of a microbial product containing Enterococcus faecium (DSM 7134) and Lactobacillus rhamnosus when
used in feed for calves for rearing (EFSA FEEDAP Panel, 2013b).
Bonvital® is currently authorised as a zootechnical additive (functional group: gut ﬂora stabiliser,
4b1841) for use in piglets, pigs for fattening,3 sows,4 chickens for fattening,5 chickens reared for
laying and minor poultry species other than those used for laying.6 The active agent E. faecium DSM
7134 is also authorised in combination with Lactobacillus rhamnosus (DSM 7133) under a different
trade name for calves for rearing.7
2. Data and methodologies
2.1. Data
The present assessment is based on data submitted by the applicant in the form of two technical
dossiers8 in support of the request for the use of Bonvital (Enterococcus faecium DSM 7134) as a feed
1 Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in
animal nutrition. OJ L 268, 18.10.2003, p. 29.
2 Lactosan GmbH & Co.Kg, Industriestrasse West 5, 8605 Kapfenberg, Austria.
3 Commission Regulation (EC) No 538/2007 of 15 May 2007 concerning the authorisation of a new use of Enterococcus faecium
DSM 7134 (Bonvital) as a feed additive. OJ L 128, 16.5.2007, p. 16.
4 Commission Regulation (EC) No 1521/2007 of 19 December 2007 concerning the authorisation of a new use of
Enterococcus faecium DSM 7134 (Bonvital) as a feed additive. OJ L 335, 20.12.2007, p. 24.
5 Commission Regulation (EU) No 998/2010 of 5 November 2010 concerning the authorisation of Enterococcus faecium DSM
7134 as a feed additive for chickens for fattening (holder of the authorisation Lactosan GmbH & Co KG. OJ L 290, 6.11.2010,
p. 22.
6 Commission Implementing Regulation (EU) No 775/2013 of 12 August 2013 concerning the authorisation of a preparation of
Enterococcus faecium DSM 7134 as a feed additive for chickens reared for laying and minor poultry species other than those
used for laying (holder of authorisation Lactosan GmbH & Co KG). OJ L 217, 13.8.2013, p. 32.
7 Commission Implementing Regulation (EU) No 1101/2013 of 6 November 2013 concerning the authorisation of a preparation
of Enterococcus faecium DSM 7134 and Lactobacillus rhamnosus DSM 7133 as a feed additive for calves for rearing and
amending Regulation (EC) No 1288/2004 (holder of authorisation Lactosan GmbH & CoKG). OJ L 296, 7.11.2013, p. 1.
8 FEED dossier references: FAD-2016-0038 and FAD-2016-0036.
Bonvital for weaned piglets and pigs for fattening
www.efsa.europa.eu/efsajournal 4 EFSA Journal 2019;17(3):5650
additive. The technical dossiers were prepared following the provisions of Article 7 of Regulation (EC)
No 1831/2003, Regulation (EC) No 429/2008 and the applicable EFSA guidance documents.
The FEEDAP Panel used the data provided by the applicant together with data from other sources,
such as previous risk assessments by EFSA, to deliver the present output.
The European Union Reference Laboratory (EURL) considered that the conclusions and
recommendations reached in the previous assessment are valid and applicable for the current
applications.9
2.2. Methodologies
The approach followed by the FEEDAP Panel to assess the safety and the efﬁcacy of Bonvital®
(Enterococcus faecium DSM 7134) is in line with the principles laid down in Regulation (EC) No 429/200810
and the relevant guidance documents: Guidance on the renewal of the authorisation of feed additives
(EFSA FEEDAP Panel, 2013c), Guidance on zootechnical additives (EFSA FEEDAP Panel, 2012a), Guidance
on the assessment of bacterial susceptibility to antimicrobials of human and veterinary importance (EFSA
FEEDAP Panel 2012b), Guidance on the safety assessment of E. faecium in animal nutrition (EFSA FEEDAP
Panel, 2012c) and Technical guidance on tolerance and efﬁcacy studies in target animals (EFSA FEEDAP
Panel, 2011).
3. Assessment
Bonvital® is a preparation consisting of viable cells of E. faecium DSM 7134, as a zootechnical
additive (functional group: gut ﬂora stabiliser) for use in piglets and pigs for fattening.
3.1. Characterisation
3.1.1. Characterisation of the additive
Bonvital® is currently authorised in two forms:
• Bonvital powder® composed of cell concentrate (3%), carrier (sweet whey powder, 96%) and
other excipients (lactose 0.5%, sodium citrate 0.1%, sodium glutamate 0.1%, sodium
ascorbate 0.05%, sodium lactate 0.2%, mannitol 0.05%) to reach a guaranteed minimum
concentration of 1 9 1010 colony forming unit (CFU)/g, and
• Bonvital granules®, microencapsulated formula, composed of cell concentrate (3%),
saccharose (70%), maltodextrin (20%), sodium citrate (1%), (sodium glutamate 1.0%, sodium
ascorbate 0.5%, sodium lactate 2.5%, mannitol 1.5%, starch 0.5%) with a guaranteed
minimum concentration 1 9 1010 CFU/g.
The applicant declared that the manufacturing process has not been changed and Bonvital® has
not been altered in composition, purity or activity since the last authorisation, and provided data
supporting it. Compliance with speciﬁcations was conﬁrmed by analysis of three batches (from 2018)
of each form (Bonvital powder®: range 1.13–1.39 9 1010 CFU/g, and Bonvital granules®: range 1.14–
1.40 9 1010 CFU/g).11
Three batches of each form produced in 2016 were analysed for chemical and microbiological purity.12
Results conﬁrm compliance with action limits (Enterobacteriaceae < 1,000 CFU/g, yeasts and ﬁlamentous
fungi < 1,000 CFU/g, Salmonella none detectable in 25 g, aﬂatoxins B1, B2, G1 and G2 < 0.03 lg/kg,
zearalenone < 5 lg/kg, deoxynivalenol < 10 lg/kg, arsenic < 1.5 mg/kg, lead < 1.0 mg/kg, cadmium
0.1 mg/kg andmercury < 0.05 mg/kg).
9 The full report is available on the EURL website: https://ec.europa.eu/jrc/en/eurl/feed-additives/evaluation-reports/fad-2008-
0007?search&form-return
10 Commission Regulation (EC) No 429/2008 of 25 April 2008 on detailed rules for the implementation of Regulation (EC)
No 1831/2003 of the European Parliament and of the Council as regards the preparation and the presentation of applications
and the assessment and the authorisation of feed additives. OJ L 133, 22.5.2008, p. 1.
11 Technical dossiers/Supplementary information February and March 2018/Annex Supp info_1.
12 Technical dossier/Section II/Annexes II.1-11, II.1-12 and II.1-13.
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3.1.2. Characterisation of the active agent
Enterococcus faecium DSM 7134 is deposited in the Deutsche Sammlung von Mikroorganismen und
Zellkulturen, under the accession number DSM 7134.13 E. faecium DSM 7134 was identiﬁed by means
of biochemical and genetic techniques, such as the sequence of the rrn operon, including the complete
16S rRNA gene, and characterised at strain level by pulsed-ﬁeld gel electrophoresis (PFGE) and
random ampliﬁcation of polymorphic DNA (RAPD) ﬁngerprinting techniques.14 RAPD and PFGE proﬁles
were used to compare the active agent with the master cell bank culture.15 No differences in the
resultant patterns were observed between the master culture and several generations of growth.
The minimum inhibitory concentration (MIC) of ampicillin for E. faecium DSM 7134 was 0.5 mg/L
and the polymerase chain reaction (PCR) analyses demonstrated the absence of the genetic
determinants IS16, hylEfm and esp, typical of hospital-associated strains as required in the guidance
on the safety assessment of E. faecium in animal nutrition (EFSA FEEDAP Panel, 2012c).16 Therefore,
E. faecium DSM 7134 does not contain marker genes typical of hospital-associated isolates responsible
for clinical infections and is considered safe.
The strain was tested for antibiotic susceptibility using twofold broth dilutions. The battery of
antibiotics tested included all of those recommended by EFSA (EFSA FEEDAP Panel, 2012b).17 As all
MIC values were equal or lower than the corresponding cut-off values deﬁned by the FEEDAP Panel,
the strain is considered susceptible to all relevant antibiotics.
3.1.3. Conditions of use
Bonvital® is currently authorised in feed for weaned piglets at the minimum dose of 5 9 108 CFU/kg
complete feed and the maximum dose of 4 9 109 CFU/kg complete feed, with the recommended dose
of 1 9 109 CFU/kg feed. The applicant now proposes the use at the minimum dose of 1 9 109 CFU/kg
complete feed and the maximum dose of 1 9 1010 CFU/kg complete feed.
Similarly, Bonvital® is currently authorised in feed for pigs for fattening at the minimum dose of
2 9 108 CFU/kg complete feed and a maximum dose of 1 9 109 CFU/kg complete feed, with the
recommended dose of 5 9 108 CFU/kg feed. The applicant now proposes to increase the maximum
dose to 2 9 109 CFU/kg complete feed.
3.2. Safety
The active agent has been identiﬁed as E. faecium. The metabolic end products of the species are
typical of lactic acid bacteria and do not raise concerns. E. faecium is not a recognised pathogen for
pigs, lacks the marker genes associated with human clinical isolates and is susceptible to relevant
antibiotics (EFSA FEEDAP Panel, 2013a). Therefore, the use of E. faecium DSM 7134 in animal
nutrition is not expected to raise concerns for the target animals or consumers of animal products.
Since neither the active agent nor the other components of the additive give rise to concerns, the
FEEDAP Panel considers the use of Bonvital safe for the target animals and consumers.
In a previous opinion, Bonvital® was found to be not irritant to skin and eyes but a potential skin/
respiratory sensitiser (EFSA FEEDAP Panel, 2013a,b,c). As Bonvital powder® has the potential to
produce a respirable dust, it is considered more hazardous for users than the granular form.
In the same opinion, the Panel concluded that Bonvital® is safe for the environment.
In order to conﬁrm that the additive remains safe under the authorised conditions of use, the
applicant submitted a tolerance study18 and two literature searches.19 However, the tolerance study
was not further considered due to the absence of replication.
The two literature searches on the safety of Bonvital® covered eight databases: Agricola, Agris,
Google Scholar, Ingenta, PubMed, Science Direct, Web of Science and World Cat Library for the period
from 2006 to 2017. The search terms used were ‘Bonvital’ or ‘Enterococcus faecium DSM 7134’ or
‘DSM 7134’ and ‘piglets’ or ‘pigs for fattening’ in one case, and ‘Bonvital’ or ‘Enterococcus faecium DSM
7134’ and ‘adverse effects’ or ‘interaction’ or ‘incompatibilities’ or ‘residues’ or ‘toxicological’ or
13 Technical dossier/Section II/Annex II.2-1.
14 Technical dossier/Section II/Annexes II.2-2 and II.2-3.
15 Technical dossier/Section II/Annex II.2-4.
16 Technical dossier/Section II/Annex II.2-5.
17 Technical dossier/Section II/Annex II.2-6.
18 Technical dossiers/Section III/Annexes III.1
19 Technical dossiers/Supplementary information February and March 2018/Annexes Supp info_2 and 3.
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‘epidemiological’ or ‘safety’ or ‘environment’ or ‘human’ in the second case. A total of 16 publications
ﬁtted with the criteria of the ﬁrst search; however, they concerned only efﬁcacy trials (Appendix A).
None of these papers reported any safety concern related to the supplementation of the additive to
target species. The only relevant hit found in the second search was an EFSA opinion on the same
product (EFSA, 2007a).
Considering the above, the FEEDAP Panel concludes that the additive remains safe under the
authorised conditions of use.
The applicant proposed maximum use levels higher than the currently authorised (from
1 9 109 CFU/kg feed to 1 9 1010 CFU/kg feed in feed for piglets and from 1 9 109 CFU/kg feed to
2 9 109 CFU/kg feed in feed for pigs for fattening). Since neither the active agent nor the other
components of the additive give rise to concerns, the conclusions reached before are considered to
cover the higher maximum application rate proposed by the applicant.
Therefore, the Panel concludes that Bonvital® used under the proposed conditions of use is safe for
weaned piglets and pigs for fattening, consumers of products derived from animals fed Bonvital® and
the environment. Bonvital® is considered a potential skin and respiratory sensitiser.
3.3. Efﬁcacy
In a previous opinion, Bonvital showed the potential to be efﬁcacious at the minimum inclusion
level of 1 9 109 CFU/kg feed in weaned piglets and at 5 9 108 CFU/kg feed in pigs for fattening
(EFSA, 2007a). The minimum application rates proposed by the applicant already fall within the range
of currently authorised for piglets and pigs for fattening, and therefore, the assessment of the efﬁcacy
would not be needed. Nonetheless, the applicant has provided some additional efﬁcacy studies which
are described below.
3.3.1. Efﬁcacy for piglets
Four studies were submitted, three performed in the same Member State but in three different
locations and one in a non-European country. This latter was the tolerance trial cited in Section 3.2,
which cannot be further considered for the reasons explained above.20
The design of the studies is presented in Table 1 and the results in Table 2. In study 1,21 weaned
piglets were distributed based on weight and gender in four experimental groups: one receiving the
basal unsupplemented diets, the second receiving the basal diets supplemented with Bonvital®
providing 1 9 109 CFU/kg feed and the other two receiving different additives. Results obtained with
the other additives were not considered by the working group. Studies 222 and 323 followed a similar
design with two experimental groups; one receiving the basal unsupplemented diets and the second
receiving the basal diets supplemented with Bonvital®. Study 1 included mixed-sex pens, study 3
single-sexed-pens, while in study 2, the sex was not speciﬁed, but the experiment included the same
number of females and males. The diets were offered to the animals ad libitum and the intended cell
counts were conﬁrmed by analysis. Health status was monitored throughout the experimental periods.
Individual (studies 1 and 3) or pen (study 2) weight and feed intake per pen were measured, and the
feed to gain ratio per pen was calculated. In all studies, an analysis of variance (ANOVA) was
performed with the data, including those from the relevant treatment groups only, considering as ﬁxed
effect the treatment group and as random effect the animal/pen. Since study 3 included four
consecutive batches of piglets, batch and stable were also included as random factors. The pen was
the experimental unit for all parameters.
20 Technical dossier FAD-2016-0038/Section II/Annexes IV-1.
21 Technical dossier FAD-2016-0038/Section II/Annexes IV-2/Supplementary information February 2018/Annexes Supp Info 4 and
DK 1234 Raw data.
22 Technical dossier FAD-2016-0038/Section II/Annexes IV-3/Supplementary information February 2018/Annex Supp Info 5.
23 Technical dossier FAD-2016-0038/Section II/Annexes IV-4/Supplementary information February 2018/Annex Supp Info 6.
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Supplementation of the additive signiﬁcantly improved the feed to gain ratio of animals in all
studies.
The additional studies provided conﬁrm the conclusions already expressed in the previous opinion
(EFSA, 2007a) that Bonvital® has the potential to be efﬁcacious in weaned piglets at 1 9 109 CFU/kg
feed.
3.3.2. Efﬁcacy for pigs for fattening
Three studies conducted in the same Member State but in two different locations were submitted.
The design of the studies is presented in Table 3 and the results in Table 4. In all studies, animals
were divided into pens in order to have a homogeneous distribution based on body weight and
gender. Studies 124 and 325 involved single-sex pens while study 226 had mixed-sex pens. Pens were
allocated to two experimental groups: one receiving the unsupplemented basal diets, and the second
receiving the basal diets supplemented with the additive in order to provide 2 9 108 CFU/kg feed.
Concentration in feed was conﬁrmed by analysis. The animals were fed ad libitum. Pen feed intake
was measured at the end of the feeding periods in study 1 and on a daily basis in studies 2 and 3.
Pigs were individually weighed at the beginning and end of the trial and feed to gain ratio was
calculated per pen. In study 3, all the pigs were killed at 116 kg body weight and the length of the
fattening period was also subject to analysis. Morbidity and mortality were monitored in all studies.
Growth data were analysed using an ANOVA with the ﬁxed effect of the group and the random effect
of the pen (for weight). Feed intake and feed to gain ratio were analysed with a linear model in study
1, and with t-test and U-test in studies 2 and 3. The experimental unit was the pen for all parameters.
Table 1: Details on the study design for the studies performed in weaned piglets
Study
Breed
(Age in days)
(Sex)
Total animals
Replicates/
treatment
3
animals/replicate
Duration of
the study
(days)
Basal diets
(main ingredients)
form
1 (Yorkshire 9 Landrace) 9 Duroc
(25)
30♀, 40♂
70
7 9 5
42 Extruded maize/soybean
meal/ﬁsh meal mash
2 Hybrids BHZP 9 (Large White 9
Landrace)
(25)
14♀, 14♂
28
7 9 2
42 Maize/soybean meal, barley,
wheat mash
3 BHZP
(25)
189♀, 191♂
380
16 9 12(a)
47 Maize/soybean meal/wheat
bran/ﬁsh meal mash
(a): Four pens contained 11 animals.
Table 2: Overview of results of efﬁcacy studies with Bonvital® in weaned piglets
Study
Bonvital®
(CFU/kg
feed)
Initial
weight
(kg)
Final
weight
(kg)
Feed
intake
(g/d)
Average daily
gain
(g/d)
Feed to
gain
ratio
Mortality
(n)
1 0
1 9 109
6.7
6.7
24.3
25.7
646
641
419b
451a
1.54a
1.42b
0
0
2 0
1 9 109
7.3
7.3
26.9
27.6
691
676
466
483
1.49a
1.40b
0
0
3 0
1 9 109
7.8
7.9
31.8
32.4
799
799
509
523
1.58a
1.53b
1
1
a,b: Means in a column within a given trial with different superscript letters are signiﬁcantly different p ≤ 0.05.
24 Technical dossier FAD-2016-0036/Section II/Annexes IV-1.
25 Technical dossier FAD-2016-0036/Section II/Annexes IV-3 and Supplementary information March 2018/Annex Supp_Info 5.
26 Technical dossier FAD-2016-0036/Section IV/Annexes IV-2 and Supplementary information March 2018/Annex Supp_Info 4.
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Supplementation of the additive led to a signiﬁcantly greater average daily gain in two trials (1 and
3) and a signiﬁcantly better feed to gain ratio in one of these trials (study 1) and in the second trial
(study 2). In study 3, the fattening period (to reach 116 kg) was also signiﬁcantly reduced in the
Bonvital® group (control: 105 vs Bonvital®: 97 days, p = 0.029).
Based on the new studies provided, the FEEDAP Panel concludes that Bonvital® has the potential to
be efﬁcacious in pigs for fattening at 2 9 108 CFU/kg feed.
4. Post-market monitoring
The FEEDAP Panel considers that there is no need for speciﬁc requirements for a post-market
monitoring plan other than those established in the Feed Hygiene Regulation27 and Good
Manufacturing Practice.
5. Conclusions
The applicant has provided evidence that the additive currently in the market complies with the
conditions of authorisation.
The FEEDAP Panel concludes that the additive remains safe under the authorised conditions of use
for the target animals, consumers, users and the environment. The higher inclusion rates proposed by
the applicant are also considered safe. Therefore, the Panel concludes that Bonvital® used under the
Table 3: Details on the study design for the studies performed in pigs for fattening
Study
Breed
Age in days
(Sex)
Total animals
Replicates/
treatment
3
animals/
replicate
Duration of the
study
(days)
Basal diets
(main ingredients)
form
1 DanBred 9 Pietrain
75
71♀, 72♂
143
36 9 2(a)
82 (Wheat, barley, rye, soybean meal)
Mash
2 Unspeciﬁed
77
200♀, 200♂
400
8 9 25
91 (Wheat, barley, rye, soybean meal)
Mash
3 Hybrids H€ulsenberg
68
72♀, 72♂
144(b)
10/8(c) 9 7/10
105/97(d) (Wheat/triticale/soybean meal/barley)
Not speciﬁed
(a): 1 pen of the control group with 1 animal.
(b): 76 in the control and 68 in Bonvital group.
(c): 10 pens in the control (2 pens of 10 animals and 8 of 7 animals) and 8 pens in the Bonvital group (4 pens of 10 animals
and 4 pens of 7 animals).
(d): Duration was dictated by the slaughter weight of individual animals (average 105 days for the control and 97 days for the
Bonvital group).
Table 4: Overview of results of efﬁcacy studies with Bonvital® in pigs for fattening
Study
Bonvital®
(CFU/kg
feed)
Initial
weight
(kg)
Daily feed
intake
(kg/day)
Final
weight
(kg)
Average daily
gain
(g/d)
Feed:gain
Mortality and
removals (n)
1 0
2 9 108
31.5a
28.3b
2.64
2.62
116
117
1026b
1083a
2.57a
2.42b
0
0
2 0
2 9 108
25.4
25.5
2.56
2.50
115
116
987
995
2.63a
2.55b
3
1
3 0
2 9 108
27.4
27.7
2.47b
2.58a
116(1)
116
851b
925a
2.98
2.88
1
0
a,b: Values within one column for the same study with different superscripts are different (p < 0.05).
(1): Final weight was reached at 105 days in the control group and at 97 days in the Bonvital® group.
27 Regulation (EC) No 183/2005 of the European Parliament and of the Council of 12 January 2005 laying down requirements for
feed hygiene. OJ L 35, 8.2.2005, p. 1.
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proposed conditions of use is safe for weaned piglets and pigs for fattening, consumers of products
derived from animals fed Bonvital® and the environment. Bonvital® is considered a potential skin and
respiratory sensitiser.
Bonvital® has the potential to be efﬁcacious in weaned piglets at 1 9 109 CFU/kg feed and in pigs
for fattening at 2 9 108 CFU/kg feed.
Documentation provided to EFSA
1) Bonvital – Pigs for fattening. June 2016. Submitted by Lactosan GmbH; Co. KG
2) Bonvital – Pigs for fattening. Supplementary information. March 2018. Submitted by Lactosan
GmbH; Co. KG
3) Bonvital Piglets. June 2016. Submitted by Lactosan GmbH; Co. KG
4) Bonvital Piglets. Supplementary information. February 2018. Submitted by Lactosan GmbH;
Co. KG
5) Comments from Member States.
Chronology EFSA-Q-2016-00452
Date Event
3/6/2016 Dossier received by EFSA
6/7/2016 Reception mandate from the European Commission
5/10/2016 Application validated by EFSA – Start of the scientiﬁc assessment
10/10/2017 Request of supplementary information to the applicant in line with Article 8(1)(2) of Regulation
(EC) No 1831/2003 – Scientiﬁc assessment suspended. Issues: characterisation, safety for target
species, safety for the consumer, safety for the user and efﬁcacy
5/1/2017 Comments received from Member States
26/2/2018 Reception of supplementary information from the applicant - Scientiﬁc assessment re-started
27/2/2019 Opinion adopted by the FEEDAP Panel. End of the Scientiﬁc assessment
Chronology EFSA-Q-2016-00450
Date Event
3/6/2016 Dossier received by EFSA
6/7/2016 Reception mandate from the European Commission
5/10/2016 Application validated by EFSA – Start of the scientiﬁc assessment
10/10/2017 Request of supplementary information to the applicant in line with Article 8(1)(2) of Regulation
(EC) No 1831/2003 – Scientiﬁc assessment suspended. Issues: characterisation and safety for
target species, consumer, user and environment and efﬁcacy
5/1/2017 Comments received from Member States
15/3/2018 Reception of supplementary information from the applicant - Scientiﬁc assessment re-started
27/2/2019 Opinion adopted by the FEEDAP Panel. End of the Scientiﬁc assessment
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